Researchers have discovered an enzyme, PapB, that can ‘tie off’ therapeutic peptides into stable rings, which could help ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.

A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

A breakthrough study reveals a new antibody that could transform the fight against HIV, neutralising over 98 percent of ...

AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...

Explore the impact of lysosomal lipid recycling in a rare multi-organ disorder linked to the SPNS1 gene mutations.

Explore the challenges of CNS drug development for neurodegenerative diseases and the complexity of measuring disease ...

New research has discovered how Rab proteins control the delivery of critical supplies to strengthen neural connections, providing researchers with important insights into memory formation and ...

CRISPR therapies depend on delivery and lipid nanoparticles are emerging as a more flexible and scalable option than viral vectors. Gene editing through clustered regularly interspaced short ...

14 October 2025 | By Dr Jack Scannell (CEO of Etheros Pharmaceuticals Corp), Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers) Drug discovery now costs 100 times more per FDA-approved drug ...